Recent events have drawn attention to the prejudice and discrimination faced by transpeople; however, there is limited research on attitudes toward transpeople. We studied the effects of facial appearance on the evaluations of transsexuals in 239 heterosexual undergraduate students from the midwestern United States. Men had significantly more negative evaluations than women. The gender of the transsexual (male-to-female or female-to-male) had limited effects on evaluations; however, the transsexual whose facial appearance was congruent with their desired gender was perceived as more attractive than the transsexual whose facial appearance was incongruent. Negative evaluations were correlated with higher levels of transphobia and sexual prejudice. Further investigation is needed on the factors that influence prejudicial attitudes toward transpeople, including physical appearance.

Substance use is known to negatively impact outcomes in patients living with HIV by decreasing adherence to and effectiveness of antiretroviral therapies. Alcohol and other drug abuse and dependence are widespread among HIV-positive individuals, though reported rates vary greatly by study, suggesting the possibility of under-reporting. The extent to which patients minimize symptoms and the factors that influence reporting remain to be determined. The present study sought to gauge the degree to which substance use is under-reported in a primary care HIV clinic by evaluating the influence of anonymity versus confidentiality of self-report on endorsement rates. Patients (n=55) currently receiving medical treatment completed a confidential questionnaire assessing the presence of alcohol abuse, other drug misuse, and Generalized Anxiety Disorder (GAD). Another group of 55 patients completed a comparable survey, but did so anonymously. The two groups were similar in terms of demographic characteristics, but self-report of substance use differed depending on how symptoms were assessed, with anonymous questionnaires yielding significantly (p<.05) higher rates, compared to confidential surveys. Under-reporting appeared specific to alcohol and substance use, with no statistically significant differences between anonymous and confidential surveys in the proportion of patients endorsing symptoms of GAD. The fact that the screener specifically designed to identify patients in need of further evaluation produced lower rates of reported alcohol and drug use suggests that more work is needed to identify appropriate tools for accurately assessing substance use in HIV-positive patients so that adequate services and referrals can be offered to those in need.

No abstract